Cargando…
Seeing it through: translational validation of new medical imaging modalities
Medical imaging is an invaluable tool for diagnosis, surgical guidance, and assessment of treatment efficacy. The Network for Translational Research (NTR) for Optical Imaging consists of four research groups working to “bridge the gap” between lab discovery and clinical use of fluorescence- and phot...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Optical Society of America
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345805/ https://www.ncbi.nlm.nih.gov/pubmed/22574264 http://dx.doi.org/10.1364/BOE.3.000764 |
_version_ | 1782232157754753024 |
---|---|
author | Aldrich, Melissa B. Marshall, Milton V. Sevick-Muraca, Eva M. Lanza, Greg Kotyk, John Culver, Joseph Wang, Lihong V. Uddin, Jashim Crews, Brenda C. Marnett, Lawrence J. Liao, Joseph C. Contag, Chris Crawford, James M. Wang, Ken Reisdorph, Bill Appelman, Henry Turgeon, D. Kim Meyer, Charles Wang, Tom |
author_facet | Aldrich, Melissa B. Marshall, Milton V. Sevick-Muraca, Eva M. Lanza, Greg Kotyk, John Culver, Joseph Wang, Lihong V. Uddin, Jashim Crews, Brenda C. Marnett, Lawrence J. Liao, Joseph C. Contag, Chris Crawford, James M. Wang, Ken Reisdorph, Bill Appelman, Henry Turgeon, D. Kim Meyer, Charles Wang, Tom |
author_sort | Aldrich, Melissa B. |
collection | PubMed |
description | Medical imaging is an invaluable tool for diagnosis, surgical guidance, and assessment of treatment efficacy. The Network for Translational Research (NTR) for Optical Imaging consists of four research groups working to “bridge the gap” between lab discovery and clinical use of fluorescence- and photoacoustic-based imaging devices used with imaging biomarkers. While the groups are using different modalities, all the groups face similar challenges when attempting to validate these systems for FDA approval and, ultimately, clinical use. Validation steps taken, as well as future needs, are described here. The group hopes to provide translational validation guidance for itself, as well as other researchers. |
format | Online Article Text |
id | pubmed-3345805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Optical Society of America |
record_format | MEDLINE/PubMed |
spelling | pubmed-33458052012-05-09 Seeing it through: translational validation of new medical imaging modalities Aldrich, Melissa B. Marshall, Milton V. Sevick-Muraca, Eva M. Lanza, Greg Kotyk, John Culver, Joseph Wang, Lihong V. Uddin, Jashim Crews, Brenda C. Marnett, Lawrence J. Liao, Joseph C. Contag, Chris Crawford, James M. Wang, Ken Reisdorph, Bill Appelman, Henry Turgeon, D. Kim Meyer, Charles Wang, Tom Biomed Opt Express Optics in Cancer Research Medical imaging is an invaluable tool for diagnosis, surgical guidance, and assessment of treatment efficacy. The Network for Translational Research (NTR) for Optical Imaging consists of four research groups working to “bridge the gap” between lab discovery and clinical use of fluorescence- and photoacoustic-based imaging devices used with imaging biomarkers. While the groups are using different modalities, all the groups face similar challenges when attempting to validate these systems for FDA approval and, ultimately, clinical use. Validation steps taken, as well as future needs, are described here. The group hopes to provide translational validation guidance for itself, as well as other researchers. Optical Society of America 2012-03-22 /pmc/articles/PMC3345805/ /pubmed/22574264 http://dx.doi.org/10.1364/BOE.3.000764 Text en ©2012 Optical Society of America http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License, which permits download and redistribution, provided that the original work is properly cited. This license restricts the article from being modified or used commercially. |
spellingShingle | Optics in Cancer Research Aldrich, Melissa B. Marshall, Milton V. Sevick-Muraca, Eva M. Lanza, Greg Kotyk, John Culver, Joseph Wang, Lihong V. Uddin, Jashim Crews, Brenda C. Marnett, Lawrence J. Liao, Joseph C. Contag, Chris Crawford, James M. Wang, Ken Reisdorph, Bill Appelman, Henry Turgeon, D. Kim Meyer, Charles Wang, Tom Seeing it through: translational validation of new medical imaging modalities |
title | Seeing it through: translational validation of new medical imaging modalities |
title_full | Seeing it through: translational validation of new medical imaging modalities |
title_fullStr | Seeing it through: translational validation of new medical imaging modalities |
title_full_unstemmed | Seeing it through: translational validation of new medical imaging modalities |
title_short | Seeing it through: translational validation of new medical imaging modalities |
title_sort | seeing it through: translational validation of new medical imaging modalities |
topic | Optics in Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345805/ https://www.ncbi.nlm.nih.gov/pubmed/22574264 http://dx.doi.org/10.1364/BOE.3.000764 |
work_keys_str_mv | AT aldrichmelissab seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT marshallmiltonv seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT sevickmuracaevam seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT lanzagreg seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT kotykjohn seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT culverjoseph seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT wanglihongv seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT uddinjashim seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT crewsbrendac seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT marnettlawrencej seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT liaojosephc seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT contagchris seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT crawfordjamesm seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT wangken seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT reisdorphbill seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT appelmanhenry seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT turgeondkim seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT meyercharles seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities AT wangtom seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities |